Region MidtJylland Denmark Report issue

Government Phase 4

Organization Overview

First Clinical Trial
2017
NCT04891367
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Frank Mose | Hospitalsapoteket Region Midtjylland | Region MidtJylland Denmark | Region Midtjyllands Psykiatriske Forskningsfond | Region midtjyllands sundhedsvidenskabelige forskningsfond